5′UTR variants of ribosomal protein S19 transcript determine translational efficiency: Implications for Diamond-Blackfan anemia and tissue variability

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Badhai, Jitendra ^a,b   Schuster, Jens ^a   Gidlöf, Olof ^a,c   Dahl, Niklas ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RIBOSOME PROTEIN; RIBOSOME PROTEIN S19; UNCLASSIFIED DRUG; RIBOSOMAL PROTEIN S19;

5' UNTRANSLATED REGION; ARTICLE; BLACKFAN DIAMOND ANEMIA; CELL STRAIN K 562; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; PROTEIN PROCESSING; PROTEIN SYNTHESIS; TESTIS; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION SITE; TRANSLATION REGULATION; ANTIBODY SPECIFICITY; CELL LINE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION;

5' UNTRANSLATED REGIONS; ANEMIA, DIAMOND-BLACKFAN; BASE SEQUENCE; CELL LINE; GENE EXPRESSION PROFILING; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; ORGAN SPECIFICITY; PROTEIN BIOSYNTHESIS; RIBOSOMAL PROTEINS; RNA, MESSENGER; TRANSCRIPTION INITIATION SITE;

EID: 79952615834     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017672     Document Type: Article

References (39)

1. Ellis SR, Lipton JM, (2008) Diamond Blackfan anemia: a disorder of red blood cell development. Curr Top Dev Biol 82: 217-241.
2. Draptchinskaia N, Gustavsson P, Andersson B, Pettersson M, Willig TN, et al. (1999) The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet 21: 169-175.
3. Boria I, Garelli E, Gazda HT, Aspesi A, Quarello P, et al. (2010) The ribosomal basis of Diamond-Blackfan Anemia: mutation and database update. Hum Mutat 31: 1269-1279.
4. Gazda HT, Zhong R, Long L, Niewiadomska E, Lipton JM, et al. (2004) RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations. Br J Haematol 127: 105-113.
5. Gregory LA, Aguissa-Toure AH, Pinaud N, Legrand P, Gleizes PE, et al. (2007) Molecular basis of Diamond-Blackfan anemia: structure and function analysis of RPS19. Nucleic Acids Res 35: 5913-5921.
6. Devlin EE, Dacosta L, Mohandas N, Elliott G, Bodine DM, (2010) A transgenic mouse model demonstrates a dominant negative effect of a point mutation in the RPS19 gene associated with Diamond-Blackfan anemia. Blood 116: 2826-2835.
7. Schuster J, Fröjmark AS, Nilsson P, Badhai J, Virtanen A, et al. (2010) Ribosomal protein S19 binds to its own mRNA with reduced affinity in Diamond-Blackfan anemia. Blood Cells Mol Dis 45: 23-28.
8. Choesmel V, Fribourg S, Aguissa-Toure AH, Pinaud N, Legrand P, et al. (2008) Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder. Hum Mol Genet 17: 1253-1263.
9. Choesmel V, Bacqueville D, Rouquette J, Noaillac-Depeyre J, Fribourg S, et al. (2007) Impaired ribosome biogenesis in Diamond-Blackfan anemia. Blood 109: 1275-1283.
10. Flygare J, Aspesi A, Bailey JC, Miyake K, Caffrey JM, et al. (2007) Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood 109: 980-986.
11. Badhai J, Fröjmark AS, Davey E, Schuster J, Dahl N, (2009) Ribosomal protein S19 and S24 insufficiency cause distinct cell cycle defects in Diamond-Blackfan anemia. Biochim Biophys Acta 1792: 1036-1042.
12. Ellis SR, Massey AT, (2006) Diamond Blackfan anemia: A paradigm for a ribosome-based disease. Med Hypotheses 66: 643-648.
13. Martinez Barrio A, Eriksson O, Badhai J, Frojmark AS, Bongcam-Rudloff E, et al. (2009) Targeted resequencing and analysis of the Diamond-Blackfan anemia disease locus RPS19. PLoS One 4: e6172.
14. Cretien A, Proust A, Delaunay J, Rince P, Leblanc T, et al. (2010) Genetic variants in the noncoding region of RPS19 gene in Diamond-Blackfan anemia: potential implications for phenotypic heterogeneity. Am J Hematol 85: 111-116.
15. Proust A, Da Costa L, Rince P, Landois A, Tamary H, et al. (2003) Ten novel Diamond-Blackfan anemia mutations and three polymorphisms within the rps19 gene. Hematol J 4: 132-136.
16. Ramenghi U, Campagnoli MF, Garelli E, Carando A, Brusco A, et al. (2000) Diamond-Blackfan Anemia: Report of Seven Further Mutations in the RPS19 Gene and Evidence of Mutation Heterogeneity in the Italian Population. Blood Cells, Molecules, and Diseases 26: 417-422.
17. Huang Q, Robledo S, Wilson DB, Bessler M, Mason PJ, (2006) A four base pair insertion in exon 1 of the RPS19 gene is a common polymorphism in African-Americans. Br J Haematol 135: 745-746.
18. Wang G, Guo X, Floros J, (2005) Differences in the translation efficiency and mRNA stability mediated by 5′-UTR splice variants of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol 289: L497-508.
19. Lopez-Lastra M, Rivas A, Barria MI, (2005) Protein synthesis in eukaryotes: the growing biological relevance of cap-independent translation initiation. Biol Res 38: 121-146.
20. Hughes TA, (2006) Regulation of gene expression by alternative untranslated regions. Trends Genet 22: 119-122.
21. van der Velden AW, Thomas AA, (1999) The role of the 5′ untranslated region of an mRNA in translation regulation during development. Int J Biochem Cell Biol 31: 87-106.
22. Stoneley M, Willis AE, (2003) Aberrant regulation of translation initiation in tumorigenesis. Curr Mol Med 3: 597-603.
23. Pickering BM, Willis AE, (2005) The implications of structured 5′ untranslated regions on translation and disease. Semin Cell Dev Biol 16: 39-47.
24. Meyuhas O, (2000) Synthesis of the translational apparatus is regulated at the translational level. Eur J Biochem 267: 6321-6330.
25. Hamilton TL, Stoneley M, Spriggs KA, Bushell M, (2006) TOPs and their regulation. Biochem Soc Trans 34: 12-16.
26. Lozzio CB, Lozzio BB, (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45: 321-334.
27. Chen TR, (1988) Re-evaluation of HeLa, HeLa S3, and HEp-2 karyotypes. Cytogenet Cell Genet 48: 19-24.
28. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, et al. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379-387.
29. Schuster J, Karlsson T, Karlstrom PO, Sundstrom Poromaa I, Dahl N, (2010) Down-regulation of progesterone receptor membrane component 1 (PGRMC1) in peripheral nucleated blood cells associated with premature ovarian failure (POF) and polycystic ovary syndrome (PCOS). Reprod Biol Endocrinol 8: 58.
30. Strausberg RL, Camargo AA, Riggins GJ, Schaefer CF, de Souza SJ, et al. (2002) An international database and integrated analysis tools for the study of cancer gene expression. Pharmacogenomics J 2: 156-164.
31. Kondoh N, Schweinfest CW, Henderson KW, Papas TS, (1992) Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Cancer Res 52: 791-796.
32. Takagi M, Absalon MJ, McLure KG, Kastan MB, (2005) Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123: 49-63.
33. Dahlqvist J, Klar J, Tiwari N, Schuster J, Torma H, et al. (2010) A single-nucleotide deletion in the POMP 5′ UTR causes a transcriptional switch and altered epidermal proteasome distribution in KLICK genodermatosis. Am J Hum Genet 86: 596-603.
34. Roberts AG, Redding SJ, Llewellyn DH, (2005) An alternatively-spliced exon in the 5′-UTR of human ALAS1 mRNA inhibits translation and renders it resistant to haem-mediated decay. FEBS Lett 579: 1061-1066.
35. Martineau Y, Le Bec C, Monbrun L, Allo V, Chiu IM, et al. (2004) Internal ribosome entry site structural motifs conserved among mammalian fibroblast growth factor 1 alternatively spliced mRNAs. Mol Cell Biol 24: 7622-7635.
36. Landers JE, Cassel SL, George DL, (1997) Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. Cancer Res 57: 3562-3568.
37. Tang H, Hornstein E, Stolovich M, Levy G, Livingstone M, et al. (2001) Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol Cell Biol 21: 8671-8683.
38. Reynolds GA, Basu SK, Osborne TF, Chin DJ, Gil G, et al. (1984) HMG CoA reductase: a negatively regulated gene with unusual promoter and 5′ untranslated regions. Cell 38: 275-285.
39. Sobczak K, Krzyzosiak WJ, (2002) Structural determinants of BRCA1 translational regulation. J Biol Chem 277: 17349-17358.